Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

Wen, MM; Xia, JH; Sun, Y; Wang, XJ; Fu, XH; Zhang, YN; Zhang, ZP; Zhou, YG; Li, XF

Zhang, ZP; Li, XF (reprint author), Tangdu Hosp, Dept Thorac Surg, Xinsi Rd, Xian 710038, Shaanxi, Peoples R China.

BIOLOGICS-TARGETS & THERAPY, 2018; 12 (): 183

Abstract

Purpose: Both epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy are widely applied for the treatment of advance......

Full Text Link